Pneumococcal vaccine reduces ear infections, pneumonia
The pneumococcal conjugate vaccine, which has been routinely given to young children since 2000, reduces the incidence of middle ear infection and pneumonia, a new study shows.
“This highlights that the vaccine significantly decreases illnesses in children and reinforces its importance in our public health efforts,” said Dr. Kathy Poehling, assistant professor of Pediatrics at Vanderbilt University Medical Center and Vanderbilt Childrens Hospital in Nashville. The study appears in the September issue of the journal “Pediatrics.”
The pneumococcal conjugate vaccine is well known to control bacterial meningitis and bacteremia — a bacterial infection in the blood system — but doctors needed good evidence that it helped control other illnesses. Ear infections (otitis media) and pneumonia are common infections in children; there are more than seven million cases of ear infection and more than one half million cases of pneumonia each year.
Poehling and colleagues studied data from Tennessees Medicaid records and from three commercial insurance companies in upstate New York. They found that after routine vaccination with the pneumococcal conjugate vaccine began children in Tennessee younger than 2 years old had 7 percent fewer cases of otitis media in Tennessee; 20 percent of these children New York got ear infections.
Likewise, there were 17 percent fewer cases of pneumonia in Tennessee and 30 percent fewer cases in New York. These translate to about 10 fewer doctor visits, per 100 children, in Tennessee for ear infections and 40 fewer in New York; there were two fewer visits, per 100, for pneumonia in Tennessee and four fewer in New York. “The cost control implications — reducing emergency department and outpatient visits — are also very important,” Poehling said.
The study provides “the first data that demonstrate a decline in all pneumococcal-related diseases, not just invasive disease, in children aged younger than 2 years since the introduction of pneumococcal conjugate vaccine in the United States,” Poehling and colleagues wrote in the journal.
Media Contact
More Information:
http://www.vanderbilt.eduAll latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Newest articles
After 25 years, researchers uncover genetic cause of rare neurological disease
Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…
Lower dose of mpox vaccine is safe
… and generates six-week antibody response equivalent to standard regimen. Study highlights need for defined markers of mpox immunity to inform public health use. A dose-sparing intradermal mpox vaccination regimen…
Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids
EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…